Vaccinating Children And Adolescents Against Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2)-The Israeli Experience

We read with interest the Letter by Verd et al. commenting on our Editorial regarding vaccination of children and adolescent against severe acute respiratory syndrome corona virus 2 (SARS-CoV-2). Indeed, when deciding on vaccination policy against SARS-CoV-2 many considerations need to be examined, including the safety of vaccines, the effectiveness in preventing illness (mainly severe), the impact on transmission of the virus, and effect of vaccination on disease prevention at the community and country level.